Compliance and adherence is a bit issue in chronic diseases even in developed countries …
Compliance and adherence is a bit issue in chronic diseases even in developed countries
Low treatment compliance is a big problem for an optimum health care delivery and decreases dramatically drug effectiveness (and revenues)
Reasons for non-adherence are related to product, patient and physician communication. Approaches that don’t focus on persons don’t work. Approaches removing obstacles work but those focused on people work better.
Many of adherence and compliance causes can be addressed with education. Education can also help to fix other business issues
Traditional educational “top-down” approach is a long and inefficient path. New approach can be much faster and effective, more customized and more responsive and long-term sustainable.
Education must be not only information, but a structured process of knowledge transfer that combines different strategies to achieve measurable behavioural changes (and business objectives.
Xeristar is educating general physicians to increase treatment compliance in depression.
AFAL (Alzheimer Families Association) is educating relatives in appropriate patient care. Our approach is based in value, end-to-end solutions, technology, innovation and customer satisfaction